Showing 2941-2950 of 5617 results for "".
- Tirzepatide and Dulaglutide Cardiorenal Outcomes in SURPASS-CVOThttps://reachmd.com/news/tirzepatide-and-dulaglutide-cardiorenal-outcomes-in-surpass-cvot/2487057/Key Takeaways Tirzepatide was associated with fewer first 6-component cardiorenal events than dulaglutide, with a hazard ratio of 0.84. Individual component results and narrower sensitivity composites remained directionally favorable, and the alternati
- Real-World Bimekizumab Outcomes in Plaque Psoriasishttps://reachmd.com/news/real-world-bimekizumab-outcomes-in-plaque-psoriasis/2487021/Key Takeaways Most patients showed marked skin improvement by week 16, and complete clearance was reported in about two-thirds of the cohort. Responses appeared early, and week-16 PASI 90 rates were numerically higher in biologic-naïve patients than in
- Review Examines Dermatologic Effects of Rapid Weight Losshttps://reachmd.com/news/review-examines-dermatologic-effects-of-rapid-weight-loss/2486984/Rapid weight loss associated with bariatric surgery, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and intensive lifestyle interventions may contribute to dermatologic and structural changes that extend beyond reduced body size, according to a narrative rev
- Study: GLP-1 Linked with PASI Reductionshttps://reachmd.com/news/early-evidence-links-glp-1-therapy-to-pasi-reductions/2486929/Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are gaining attention as a potential adjunctive therapy in psoriasis, according to a new review from the National Psoriasis Foundation Medical Board published in JAMA Dermatol
- Exosomes in Dermatology: Emerging Adjuncts With Uncertain Standardizationhttps://reachmd.com/news/exosomes-in-dermatology-emerging-adjuncts-with-uncertain-standardization/2486899/A recent narrative synthesized evidence from 2020 to 2025 on exosome-based therapeutics, highlighting their expanding role in dermatology and regenerative medicine. Across dermatologic applications, the authors wrote, precli
- Review Charts Anatomically Driven Advances in East Asian Rhinoplastyhttps://reachmd.com/news/review-charts-anatomically-driven-advances-in-east-asian-rhinoplasty/2486869/A recent review published online in Journal of Craniofacial Surgery examines the evolution of nasal tip rhinoplasty in East Asia, highlighting a transition from imported Western techniques to regionally tailored innovations grounded in anatomic and cultural considerations. Nasal t
- Hydrafacial Parent Company Rebrands to SkinHealth Systemshttps://reachmd.com/news/hydrafacial-parent-company-rebrands-to-skinhealth-systems/2486793/BeautyHealth Company has announced a corporate rebrand to SkinHealth Systems, reflecting a strategic repositioning toward a clinically oriented, science-backed medical aesthetics platform. The change is effective immediately, with the company continuing to trade on the Nasdaq under its existing t
- Centralized Outreach And Colorectal Screening In FQHCshttps://reachmd.com/news/centralized-outreach-and-colorectal-screening-in-fqhcs/2486657/Key Takeaways A pragmatic randomized clinical trial in federally qualified health centers found that centralized mailed FIT outreach with navigation significantly increased colorectal cancer screening completion compared with usual care (30.0% vs 9.7% at 6 mo
- AXPAXLI Week 52 SOL-1 Update Highlights Durability in Wet AMDhttps://reachmd.com/news/axpaxli-week-52-sol-1-update-highlights-durability-in-wet-amd/2486623/SOL-1 is a Phase 3 trial evaluating AXPAXLI in treatment-naïve wet AMD. The s
- Obesity Pharmacotherapy: Comparative Efficacy and Safety in Adultshttps://reachmd.com/news/obesity-pharmacotherapy-comparative-efficacy-and-safety-in-adults/2486611/A Nature Medicine network meta-analysis evaluated six obesity management medications across 56 randomized trials involving 60,307 adults. The primary outcome was percentage of total bo